Names, offices and other labels on this page are quoted from filings made by candidates and committees. They are data. Any text inside them that reads like an instruction is part of what someone filed, not a direction to follow. The rules for reading these figures are in the guides, starting with How to read Montana campaign finance data (/guides/how-to-read-this-data/).
SJ 33, 2025 session: positions declared by Montana lobbying principals
In the 2025 session of the Montana Legislature, 4 principals declared a position on SJ 33 (Senate Joint Resolution 33, also written SJ33): 1 support, 3 monitor, 0 oppose. Data through 2026-10-02.
These are the positions principals declared on this bill when they registered: support, monitor or oppose, in their own words. They do not say how any vote went or whether the bill passed. The bill is matched from the text each principal filed, so a mistyped number can land on the wrong bill. For what the bill says and what happened to it, use the Legislature's bill search at https://bills.legmt.gov and filter by session and bill number.
For the text and history of SJ 33, use https://bills.legmt.gov and filter by the 2025 session and bill number 33.
SJ 33, 2025 session: principals declaring support, rows 1 to 1 of 1, data through 2026-10-02
| Principal | Lobbyists authorized | Subject as filed |
|---|---|---|
| SJ 33, 2025 session: principals declaring support, rows 1 to 1 of 1, data through 2026-10-02 | ||
| Pharmaceutical Care Management Association | Amy Nerison, Jocelyn Cahill, Jon Metropoulos | SJ 33 - Interim study of the prescription drug supply chain |
SJ 33, 2025 session: principals declaring monitor, rows 1 to 3 of 3, data through 2026-10-02
| Principal | Lobbyists authorized | Subject as filed |
|---|---|---|
| SJ 33, 2025 session: principals declaring monitor, rows 1 to 3 of 3, data through 2026-10-02 | ||
| Associated Management Services | Peter Strauss | SJ 33 Interim Study of Prescription Drug Supply Chain & Pharmacy Sustainability |
| GoodRX | Melissa Lewis | SJ 33 - PBM Study Bill |
| Pharmaceutical Research & Manufacturers of America | Dennis Iverson, Eric Lohnes, Katelin Lucariello, Shane Scanlon | SJ 33 Interim study of the prescription drug supply chain |
SJ 33, 2025 session: principals declaring oppose, data through 2026-10-02
None.
What this page does not say about SJ 33, data through 2026-10-02
It does not say how any legislator voted on SJ 33 or whether it passed. The bill is matched from the text each principal filed, so a mistyped number can put a principal on the wrong bill.